Neuroscience

AdventHealth Collaborates with Aidoc for One of the Largest Imaging AI Deployments in the U.S.AdventHealth Collaborates with Aidoc for One of the Largest Imaging AI Deployments in the U.S.

AdventHealth Collaborates with Aidoc for One of the Largest Imaging AI Deployments in the U.S.

The collaboration aims to support care coordination and enhance patient safety at AdventHealth. NEW YORK, Nov. 20, 2025 /PRNewswire/ --…

16 hours ago
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy ProgramsAspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs

Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs

SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the…

16 hours ago
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular DementiaDr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia

Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia

Calgary, Alberta--(Newsfile Corp. - November 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's…

19 hours ago
Axsome Therapeutics to Participate in Upcoming Investor ConferencesAxsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

19 hours ago
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting…

19 hours ago
Seedtag Releases First-of-Its-Kind Neuroscience Study Redefining Human-Centered Advertising EffectivenessSeedtag Releases First-of-Its-Kind Neuroscience Study Redefining Human-Centered Advertising Effectiveness

Seedtag Releases First-of-Its-Kind Neuroscience Study Redefining Human-Centered Advertising Effectiveness

Brain activity study shows Neuro-Contextual advertising drives 3.5x higher neural engagement and 26% lift in positive, action-driving response NEW YORK,…

2 days ago
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of DirectorsMinerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors

Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors

BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development…

2 days ago
Mount Sinai Medical Center Achieves HIMSS EMRAM Stage 7 ValidationMount Sinai Medical Center Achieves HIMSS EMRAM Stage 7 Validation

Mount Sinai Medical Center Achieves HIMSS EMRAM Stage 7 Validation

South Florida hospital recognized at the highest level of digital care excellence MIAMI BEACH, Fla., Nov. 18, 2025 /PRNewswire/ --…

2 days ago
Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer’s Detection and Clinical Trial Readiness at CTAD 2025Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer’s Detection and Clinical Trial Readiness at CTAD 2025

Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer’s Detection and Clinical Trial Readiness at CTAD 2025

BOSTON, Nov. 18, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and…

3 days ago